Cannabinoid Receptor 2 Signaling Does Not Modulate Atherogenesis in Mice

The Endocannabinoid System and Pain

(2012) Josee Guindon et al.   CNS & Neurological Disorders-Drug Targets

Cannabinoid 1 Receptor Blockade Reduces Atherosclerosis with Enhances Reverse Cholesterol Transport

(2011) Koichi Sugamura et al.   Journal of Atherosclerosis and Thrombosis

Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice

(2010) Courtney D. Netherland et al.   ATHEROSCLEROSIS

Tumor Necrosis Factor Receptor–Associated Factor 1 (TRAF1) Deficiency Attenuates Atherosclerosis in Mice by Impairing Monocyte Recruitment to the Vessel Wall

(2010) Anna Missiou et al.   CIRCULATION

Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion Molecules

(2010) Yan Zhao et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Immune and Inflammatory Mechanisms of Atherosclerosis

(2009) Elena Galkina et al.   Annual Review of Immunology

Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis

(2009) Fabrizio Montecucco et al.   ATHEROSCLEROSIS

CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages

(2009) K. H. Han et al.   CARDIOVASCULAR RESEARCH

Immune System and Atherosclerotic Disease

(2009) Kazunori Shimada   CIRCULATION JOURNAL

The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy

(2009) Nicole Defer et al.   FASEB JOURNAL

Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment

(2009) Sasidhar Murikinati et al.   FASEB JOURNAL

CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion

(2009) Fabrizio Montecucco et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways

(2008) Fabrizio Montecucco et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice

(2008) Frédérique Dol-Gleizes et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages

(2008) Koichi Sugamura et al.   CIRCULATION

Cannabinoid (CB2) receptor deficiency reduces the susceptibility of macrophages to oxidized LDL/oxysterol-induced apoptosis

(2008) Natalie E. Freeman-Anderson et al.   JOURNAL OF LIPID RESEARCH

The Role of the Endocannabinoid System in Atherosclerosis

(2008) F. Mach et al.   JOURNAL OF NEUROENDOCRINOLOGY

Targeting the endocannabinoid system: to enhance or reduce?

(2008) Vincenzo Di Marzo   NATURE REVIEWS DRUG DISCOVERY

CB2receptor-mediated migration of immune cells: it can go either way

(2007) A M Miller et al.   BRITISH JOURNAL OF PHARMACOLOGY